» Articles » PMID: 35473486

Exploration of Attitudes Regarding Uptake of COVID-19 Vaccines Among Vaccine Hesitant Adults in the UK: a Qualitative Analysis

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2022 Apr 27
PMID 35473486
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this work was to explore barriers and facilitators to uptake of COVID-19 vaccines and to explore views and reactions to efforts to improve vaccine uptake among vaccine hesitant individuals.

Methods: Semi-structured interviews were conducted with people between the age of 18-29 years who had not had a COVID-19 vaccine, and those between 30 and 49 years who had not had a second dose of a COVID-19 vaccine.

Results: A total of 70 participants took part in the study, 35 participants had received one dose, and 35 had not been vaccinated. Participants described a willingness to be vaccinated to keep themselves and those around them safe and to avoid restrictions. Barriers to uptake included: (1) perceived lack of need for COVID-19 vaccinations, (2) concerns about the efficacy of vaccinations, (3) concerns about safety, and (4) access issues. Uptake appeared to be influenced by age and health status, trust in government, and knowledge and understanding of science. Introduction of vaccine passes may provide a motive for having a vaccine but may be viewed as coercive.

Conclusion: Participants were hesitant, rather than opposed, and had questions about their need for, and the safety and efficacy of the vaccine. Young people did not consider themselves to be at risk of becoming ill from COVID-19, did not think the vaccination was effective in preventing transmission, and did not think sufficient research had been conducted regarding possible long-term side-effects. Concerns were exacerbated by a lack of trust in government, and misunderstanding of science. To promote uptake, public health campaigns should focus on the provision of information from trusted sources that explains the benefits of vaccination and addresses safety concerns more effectively. To overcome inertia in people with low levels of motivation to be vaccinated, appointments must be easily accessible.

Citing Articles

What made people (more) positive toward the COVID-19 vaccine? Exploring positive and negative deviance perspectives.

Matthijssen M, Cloin M, van Leeuwen F, van de Goor I, Achterberg P BMC Public Health. 2025; 25(1):441.

PMID: 39905331 PMC: 11792343. DOI: 10.1186/s12889-024-21027-1.


Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period.

Hayek S, Levy J, Shaham G, Dagan N, Serby D, Duskin-Bitan H Infect Dis Ther. 2025; 14(2):433-445.

PMID: 39762664 PMC: 11829863. DOI: 10.1007/s40121-024-01100-3.


Factors that influence recruitment to COVID-19 vaccine trials: a qualitative evidence synthesis.

Biesty L, Sheehan S, Meskell P, Dowling M, Glenton C, Shepperd S Trials. 2024; 25(1):837.

PMID: 39696633 PMC: 11657826. DOI: 10.1186/s13063-024-08670-0.


Determinants of COVID-19 vaccination acceptance based on the novel Omale INDEPT FORCIS Framework and recommendations for subsequent pandemics: a qualitative study among community members in Ebonyi state, Nigeria.

Omale U, Adeke A, Oka O, Ikegwuonu C, Iyare O, Nnachi O Int J Equity Health. 2024; 23(1):223.

PMID: 39468612 PMC: 11520843. DOI: 10.1186/s12939-024-02284-3.


Understanding facilitators and barriers to COVID-19 vaccination in the Zimbabwean population: a qualitative analysis.

Midzi N, Mutsaka-Makuvaza M, Charimari L, Mangwiro P, Manengureni T, Mugadza G BMC Public Health. 2024; 24(1):1174.

PMID: 38679733 PMC: 11057155. DOI: 10.1186/s12889-024-18650-3.


References
1.
Robertson E, Reeve K, Niedzwiedz C, Moore J, Blake M, Green M . Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav Immun. 2021; 94:41-50. PMC: 7946541. DOI: 10.1016/j.bbi.2021.03.008. View

2.
Dennis A, Robin C, Jones L, Carter H . Exploring vaccine hesitancy in care home employees in North West England: a qualitative study. BMJ Open. 2022; 12(5):e055239. PMC: 9062455. DOI: 10.1136/bmjopen-2021-055239. View

3.
Jarrett C, Wilson R, OLeary M, Eckersberger E, Larson H . Strategies for addressing vaccine hesitancy - A systematic review. Vaccine. 2015; 33(34):4180-90. DOI: 10.1016/j.vaccine.2015.04.040. View

4.
MacDonald N . Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015; 33(34):4161-4. DOI: 10.1016/j.vaccine.2015.04.036. View

5.
Vergara R, Sarmiento P, Lagman J . Building public trust: a response to COVID-19 vaccine hesitancy predicament. J Public Health (Oxf). 2021; 43(2):e291-e292. PMC: 7928772. DOI: 10.1093/pubmed/fdaa282. View